Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...
Breast health screenings can feel overwhelming, especially when medical terminology and unfamiliar procedures create anxiety about what lies ahead. Understanding breast ultrasounds removes much of ...
In a recent study published in the journal Cell, researchers describe recent advancements in breast cancer research and how these findings have improved the precise diagnosis of tumor subtypes and ...
A new study has increased the understanding of an increasingly common complication of advanced breast cancer. Using a novel approach, researchers have uncovered details of secondary breast cancer in ...
An expert explained how next-generation sequencing can help patients with metastatic breast cancer understand their disease and available treatment options. Understanding a diagnosis of estrogen ...
The landscape of breast cancer detection continues to evolve, with medical understanding now emphasizing personalized knowledge of breast tissue over rigid examination routines. This shift reflects ...
Reviewed by Eleonora Teplinsky, MD, Head of Breast Medical Oncology at Valley Health System in Paramus, New Jersey, Clinical Assistant Professor at Icahn School of Medicine at Mount Sinai in New York ...
LITTLE ROCK (KATV) — In September, the FDA will require all mammography facilities to provide patients with breast density information. Breast density is a topic that a recent national survey has ...
The number of older women living with a history of breast cancer in the U.S. is growing, which is due to new diagnoses in patients over 65 and because many women diagnosed at a younger age are living ...
Taking care of your breast health can feel overwhelming, but it doesn’t have to be. One of the simplest and most powerful things you can do for yourself is to stay informed and keep up with regular ...
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study Although the features of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results